This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In the recent UK case of Philip Morris v BAT [2023] EWHC 2616 (Pat) , His Honour Justice Hacon (Hacon HHJ) considered the standard for invalidity due to added matter. Invalidity in view of added matter is a common patent pitfall in Europe ( IPKat ). Final thoughts: Added matter versus patent profanity? Smoke Free World. "
We are pleased to bring to you this sponsored post by IP Press on the extension of the registration deadlines for their Comprehensive Course on Patents, in collaboration with S. The IP Press presents the third cohort of the Comprehensive Course on Patents. Majumdar & Co.who are experts in the field of Patents.
US patent attorneys wishing to understand certain peculiarities of European patentdrafting need look no further than the recent Board of Appeal decision in T 2171/21. The Novartis patent EP 3111954 in T 2171/21 related to the second medical use of the anti-IL-17 antibody secukinumab.
2021-2022 was a big year for the Osgoode’s mooting team entry for the USPTO National Patent Application Drafting Competition. We invite you to participate in the tryouts for the 2022-2023 National Patent Application Drafting Competition ! About the National Patent Application Drafting Competition.
PLI’s Patent Bootcamp offers an exceptionally comprehensive and interactive environment for attendees who want to learn the basics of patent application preparation, claims drafting, and prosecution, as well as recent developments in the law. Instructed by leading patent. By: Practising Law Institute (PLI)
Datzov, The Role of Patent (In)Eligibility in Promoting Artificial Intelligence Innovation , 92 UMKC L. 1, 4 (2023). AI Visualize had asserted four related patents that facilitated use of a low-bandwidth web portal for visualizing 3D/4D medical scans. Patent Nos. .” Nikola L. AI Visualize, Inc.
Though the patent system exists to promote innovation, it also serves to promote inventors and innovators. I still remember how happy I was when I filed my first patent back which was a moment of great joy and pride. And as time went by, I filed multiple patents and I felt more confident and more accomplished.”
Similar to other jurisdictions, a patent in Canada is granted for one invention only. However, care must be taken to avoid potential double patenting issues. The Supreme Court of Canada held in Whirlpool that double patenting has two types. The Supreme Court of Canada held in Whirlpool that double patenting has two types.
DNA Maine Coon The Institute of Professional Representatives before the European Patent Office (epi) raised the added matter issue with the EPO last year ( IPKat ). There is an international requirement for biological sequences disclosed in a patent application to be provided in a sequence listing document. However, converting from ST.25
However, in this Kat's view, using the amount of "similarity" between the claims and the prior art as a test for inventive step would constitute a vast oversimplification of patent law, lacking any correspondence with the established legal concepts of novelty and inventive step. features, images, text) are represented as vectors and compared.
8,671,132 (‘132 patent) unpatentable under 35 U.S.C. § 2023-1313, slip op. This post discusses the analogous arts test and provides key guidance to patent attorneys in today’s post-AIA world. The ‘132 patent, owned by appellant Daedalus, relates to a policy-based data management system for handling files.
The Patent Trial and Appeal Board’s sided with the patentee, holding that a key prior art reference was not analogous art. This case also raises questions about the value of explicitly stating the problem solved within the patent document, and perhaps directly in the patent claims. 22-1138, — F.4th 4th — (Fed.
PatKat has decided to take a look to see if any of currently available tools can assist with patentdrafting for life sciences. LLMs for patentdrafting We are now awash with companies claiming to provide LLM software capable of draftingpatent applications. So how did the Qatent tool perform?
Patent and Trademark Office to provide guidance on IP risks and related regulation to address emerging issues related to AI. Patent Law President Biden’s directive instructs the Under Secretary of Commerce for Intellectual Property and Director of the U.S. See our prior post discussing some of the patentability issues for AI.
Patent and Trademark Office to provide guidance on IP risks and related regulation to address emerging issues related to AI. Patent Law President Biden’s directive instructs the Under Secretary of Commerce for Intellectual Property and Director of the U.S. See our prior post discussing some of the patentability issues for AI.
Patent and Trademark Office to provide guidance on IP risks and related regulation to address emerging issues related to AI. Patent Law President Biden’s directive instructs the Under Secretary of Commerce for Intellectual Property and Director of the U.S. See our prior post discussing some of the patentability issues for AI.
An important question for such companies is when, and even if, to file patents for this IP. Patent protection for a new molecule entering clinical trials is how innovator pharmaceutical companies seek to ensure a return of investment for the millions of dollars required to take the drug through to market. Alfie (a.k.a.
Patents Rose Hughes analyzed DexCom v Abbott (UPC_CFI_230/2023), the first substantive decision of the Paris Local Division of the Unified Patent Court (UPC) on patent validity. Rose Hughes looked into currently available tools that can assist with patentdrafting for life sciences.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content